EUVIMEDEUVIMED entdecken
Open Access

Colocating Syringe Services, COVID-19 Vaccination, And Infectious Disease Testing: Baltimore’s Experience

Omeid Heidari, Diane Meyer, Kelly Lowensen, Amita Patil, Katie J O'Conor, Jessica LaRicci, Derrick Hunt, Adam P Bocek, Victoria Cargill, Jason E Farley

Health Affairs · 2024

DOI: 10.1377/hlthaff.2024.00032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health Affairs, 2024. Verfasst von Omeid Heidari und 9 weiteren Autor:innen. Beteiligte Einrichtung: Omeid Heidari (oheidar1@uw.edu), University of Washington, Seattle, Washington. Hauptthemen laut MEDLINE: Needle-Exchange Programs, COVID-19, COVID-19 Vaccines, Substance Abuse, Intravenous. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

People who inject drugs face many challenges that contribute to poor health outcomes, including drug overdose, HIV, and hepatitis C infections. These conditions require high-quality prevention and treatment services. Syringe services programs are evidence-based harm reduction programs, and they have established track records with people who inject drugs, earning them deep trust within this population. In Baltimore, Maryland, although many syringe support services were limited during the COVID-19 pandemic, the health department's syringe services programs remained operational, allowing for the continuation of harm reduction services, including naloxone distribution. This evaluation describes a collaborative effort to colocate infectious disease testing and COVID-19 vaccination with a syringe services program. Our evaluation demonstrated that colocation of important services with trusted community partners can facilitate engagement and is essential for service uptake. Maintaining adequate and consistent funding for these services is central to program success. Colocation of other services within syringe services programs, such as medications for opioid use disorder, wound care, and infectious disease treatment, would further expand health care access for people who inject drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Needle-Exchange ProgramsCOVID-19COVID-19 VaccinesSubstance Abuse, IntravenousHumansBaltimoreHarm ReductionHealth Services AccessibilityCOVID-19 TestingHIV Infections

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Omeid Heidari (oheidar1@uw.edu), University of Washington, Seattle, Washington.
  • Diane Meyer, Johns Hopkins University, Baltimore, Maryland.
  • Kelly Lowensen, Johns Hopkins University.
  • Amita Patil, Johns Hopkins University.
  • Katie J. O'Conor, Johns Hopkins University.
  • Jessica LaRicci, Johns Hopkins University.

Förderung

  • NCATS NIH HHS

Zitieren

APA

Heidari, O., Meyer, D., Lowensen, K., Patil, A., O'Conor, K. J., LaRicci, J., Hunt, D., Bocek, A. P., Cargill, V., & Farley, J. E. (2024). Colocating Syringe Services, COVID-19 Vaccination, And Infectious Disease Testing: Baltimore’s Experience. Health Affairs. https://doi.org/10.1377/hlthaff.2024.00032

Vancouver

Heidari O, Meyer D, Lowensen K, Patil A, O'Conor KJ, LaRicci J, et al. Colocating Syringe Services, COVID-19 Vaccination, And Infectious Disease Testing: Baltimore’s Experience. Health Affairs. 2024. doi:10.1377/hlthaff.2024.00032

BibTeX
@article{Heidari2024,
  author = {Heidari, Omeid and Meyer, Diane and Lowensen, Kelly and Patil, Amita and O'Conor, Katie J and LaRicci, Jessica and Hunt, Derrick and Bocek, Adam P and Cargill, Victoria and Farley, Jason E},
  title = {Colocating Syringe Services, COVID-19 Vaccination, And Infectious Disease Testing: Baltimore’s Experience},
  journal = {Health Affairs},
  year = {2024},
  doi = {10.1377/hlthaff.2024.00032}
}
Kostenlos starten →